Injected trivalent inactivated influenza vaccines are most commonly used throughout the world. Influenza antigen preparation varies between manufacturers.
In 2023 and until the beginning of November, over 4.5 million cases and over 4 000 dengue-related deaths have been reported from 80 countries/territories globally.
In 2023 and until the beginning of November, over 4.5 million cases and over 4 000 dengue-related deaths have been reported from 80 countries/territories globally.
In 2023, and as of 23 August, over 3.7 million cases and over 2 000 dengue-related deaths have been reported from 70 countries/territories globally. In July-August 2023, six autochthonous/non-travel associated dengue cases have been reported in Europe.